BioSpace News Archive

Drug Development

Ablynx Provides Update on Its Ongoing Phase I Study for ALX-0141

January 10, 2011
·
2 min read
Business

Emergent BioSolutions Provides Preliminary 2010 Financial Results and Guidance for 2011

January 10, 2011
·
1 min read
FDA

Abbott Laboratories Receives CE Mark Approval for World’s First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 10, 2011
·
6 min read
Deals

Smith & Nephew Inc. Jumps 13% In Spite of Rejected $10.9B Johnson & Johnson Bid

January 10, 2011
·
1 min read
Safety and Efficacy of OrbusNeich’s Genous(TM) Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy

January 10, 2011
·
4 min read
Business

Bristol-Myers Squibb Company and Pharmasset, Inc. Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C

January 10, 2011
·
7 min read
FDA

Watson Pharmaceuticals, Inc.'s Generic Fentora(R) Receives FDA Approval

January 10, 2011
·
3 min read
Drug Development

Shire plc Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII in Excessive Daytime Sleepiness (EDS)

January 10, 2011
·
12 min read